
1st N2CR Staff Retreat 2023
After 2 years, N2CR had its very first Staff Retreat! Held at the Republic of Singapore Yacht Club, our primary, secondary, affiliate and associate members came together to talk about

After 2 years, N2CR had its very first Staff Retreat! Held at the Republic of Singapore Yacht Club, our primary, secondary, affiliate and associate members came together to talk about

A/Prof Takaomi Sanda, Dr Lim Fang Qi and team have shown how PIK-75, a drug dismissed over 10 years ago, is proving vital in treating aggressive blood cancer, especially in

CanCycle 2023 is now in full swing! Thank you for all your support thus far 🙂 Read on to find more about the people you’d be making a difference to.

N2CR member, A/Prof Too Heng-Phon, Dr Sarah Ho and team have developed a way to use stem cells to treat cancer in cats and dogs, a method originally developed for

Precision Cancer Medicine thematic member, Dr Yong Wei Peng was part of a team who developed an antibody-drug conjugate (ADC), the first of its kind to be created in Singapore.

A/Prof Koh Liang Piu, member of the N2CR Tissue-Specific Carcinogenesis theme, helped to develop a cell selection technique that gives blood cancer patients a higher chance of finding a match

(image credit: The Straits Times) For the past two decades, Prof Too has played a tremendous role in strengthening life sciences research and development in Singapore. His steadfast dedication

Every year, analytics company Clarivate publishes a list of highly cited researchers who have constantly produced high impact research and published multiple highly cited papers in the last decade. This

Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The list for the citation year 2021 is accessible here: https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/4 A huge

N2CR member Associate Professor Too Heng-Phon, who co-foundered biotech firm MiRXES with two of his former PhD students, Dr Zhou Lihan and Dr Zhou Ruiyang, has developed a test kit